To further establish the connection between CRF and AVP signaling pathways and KP-13′s anxiety- and HPA axis-stimulating effect, we conducted a set of experiments in which, before the administration of KP-13, a pretreatment with non-selective CRFR or a V1R antagonist was performed. The gene discussed is CRH; the disease is Anxiety.